Potential Value and Application of Liquid Biopsy in Tumor, Neurodegeneration, and Muscle Degenerative Diseases

Methods Mol Biol. 2023:2695:317-335. doi: 10.1007/978-1-0716-3346-5_22.

Abstract

Liquid biopsy provides a promising alternative for the detection of disease-specific markers due to its superior noninvasive and original tissue representativeness. Liquid biopsies have a wide range of health and disease applications involving components ranging from circulating cells to acellular nucleic acid molecules and other metabolites. Here, we review the different components of liquid biopsy and investigate the most advanced noninvasive methods for detecting these components as well as their existing problems and trends. In particular, we emphasize the importance of analyzing liquid biopsy data from extracellular vesicles and small nucleic acids in neurological and muscle degeneration, with the aim of using this technique to enhance personalized healthcare. Although previous reviews have focused on cancer, this review mainly emphasizes the potential application of extracellular vesicles and microRNAs in liquid biopsy in neurodegeneration and muscle degeneration.

Keywords: Extracellular vesicle; Liquid biopsy; MicroRNA; Muscle degeneration; Neurodegeneration.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Extracellular Vesicles* / metabolism
  • Humans
  • Liquid Biopsy / methods
  • Muscles / metabolism
  • Muscular Diseases* / diagnosis
  • Muscular Diseases* / pathology
  • Neoplasms* / pathology
  • Neoplastic Cells, Circulating* / pathology

Substances

  • Biomarkers, Tumor